Jounce Therapeutics Inc (JNCE)

Ticker: JNCE Exchange: NSM


Loading...
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Jounce Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
MURRAY RICHARD /CA/ Non-Executive Director
Transaction date
Planned sale
Price
146.85
Quantity 57,238 -33.9%
Value US$4,381,397
3.3
TANG KEVIN C Large shareholder
Transaction date
Purchase
Price
17.10
Quantity 29,335 +32.4%
Value US$1,850,522
3.3
TANG KEVIN C Large shareholder
Transaction date
Purchase
Price
76.76
Quantity 16,806 -9.0%
Value US$4,181,609
1.9
Cole Hugh M Chief Operating Officer Officer
Transaction date
Sale
Price
1.12
Quantity 9,182 -7.7%
Value US$10,284
Trehu Elizabeth Chief Medical Officer Officer
Transaction date
Sale
Price
1.12
Quantity 5,126 -4.7%
Value US$5,741
MURRAY RICHARD /CA/ CEO and President Executive Director
Transaction date
Sale
Price
1.12
Quantity 24,879 -9.8%
Value US$27,864
Drapkin Kimberlee C CFO and Treasurer Officer
Transaction date
Sale
Price
1.12
Quantity 7,781 -10.5%
Value US$8,715
1.9
Cole Hugh M Chief Operating Officer Officer
Transaction date
Sale
Price
1.10
Quantity 7,452 -5.9%
Value US$8,197
Trehu Elizabeth Chief Medical Officer Officer
Transaction date
Sale
Price
1.10
Quantity 4,159 -3.7%
Value US$4,575
MURRAY RICHARD /CA/ CEO and President Executive Director
Transaction date
Sale
Price
1.10
Quantity 20,191 -7.4%
Value US$22,210
Drapkin Kimberlee C CFO and Treasurer Officer
Transaction date
Sale
Price
1.10
Quantity 6,315 -7.9%
Value US$6,946
Trehu Elizabeth Officer Officer
Transaction date
Proposed sale
Price
1.14
Quantity 10,000
Value US$11,400
Drapkin Kimberlee C Officer Officer
Transaction date
Proposed sale
Price
1.14
Quantity 15,000
Value US$17,100
MURRAY RICHARD /CA/ Officer; Director Executive Director
Transaction date
Proposed sale
Price
1.14
Quantity 45,000
Value US$51,300
Drapkin Kimberlee C CFO and Treasurer Officer
Transaction date
Sale
Price
6.65
Quantity 8,222 -13.5%
Value US$54,676
Trehu Elizabeth Chief Medical Officer Officer
Transaction date
Sale
Price
6.65
Quantity 5,378 -5.9%
Value US$35,764
MURRAY RICHARD /CA/ CEO and President Executive Director
Transaction date
Sale
Price
6.65
Quantity 23,924 -11.4%
Value US$159,095
1.9
Cole Hugh M Chief Business Officer Officer
Transaction date
Sale
Price
6.65
Quantity 6,205 -8.8%
Value US$41,263
Drapkin Kimberlee C CFO and Treasurer Officer
Transaction date
Sale
Price
7.30
Quantity 4,595 -7.0%
Value US$33,544
Trehu Elizabeth Chief Medical Officer Officer
Transaction date
Sale
Price
7.30
Quantity 3,005 -3.2%
Value US$21,936
MURRAY RICHARD /CA/ CEO and President Executive Director
Transaction date
Sale
Price
7.30
Quantity 13,370 -6.0%
Value US$97,601
1.9
Cole Hugh M Chief Business Officer Officer
Transaction date
Sale
Price
7.30
Quantity 3,468 -4.7%
Value US$25,316
Pfeffer Cary Non-Executive Director
Transaction date
Sale
Price
0.00
Quantity 0
Value US$0
Higgons John Duncan Non-Executive Director
Transaction date
Planned sale
Price
10.00
Quantity 200 -2.0%
Value US$2,000
Higgons John Duncan Non-Executive Director
Transaction date
Planned sale
Price
12.80
Quantity 200 -2.0%
Value US$2,560
Pfeffer Cary Non-Executive Director
Transaction date
Sale
Price
0.00
Quantity 0
Value US$0
Higgons John Duncan Non-Executive Director
Transaction date
Planned sale
Price
11.78
Quantity 200 -1.9%
Value US$2,356
1.9
Cole Hugh M Chief Business Officer Officer
Transaction date
Planned sale
Price
11.95
Quantity 18,000 -27.6%
Value US$215,100
MURRAY RICHARD /CA/ CEO and President Executive Director
Transaction date
Planned sale
Price
12.06
Quantity 33,518 -19.3%
Value US$404,227
Higgons John Duncan Non-Executive Director
Transaction date
Planned sale
Price
11.11
Quantity 200 -1.9%
Value US$2,222
Drapkin Kimberlee C CFO and Treasurer Officer
Transaction date
Planned sale
Price
12.00
Quantity 3,799 -8.1%
Value US$45,588
Drapkin Kimberlee C CFO and Treasurer Officer
Transaction date
Planned sale
Price
10.03
Quantity 10,000 -18.8%
Value US$100,300
Drapkin Kimberlee C CFO and Treasurer Officer
Transaction date
Planned sale
Price
12.03
Quantity 16,201 -23.4%
Value US$194,898
Trehu Elizabeth Chief Medical Officer Officer
Transaction date
Planned sale
Price
12.01
Quantity 6,500 -8.4%
Value US$78,065
Higgons John Duncan Non-Executive Director
Transaction date
Planned sale
Price
12.00
Quantity 1,500 -12.5%
Value US$18,000
MURRAY RICHARD /CA/ CEO and President Executive Director
Transaction date
Planned sale
Price
12.04
Quantity 16,482 -10.5%
Value US$198,443
MURRAY RICHARD /CA/ CEO and President Executive Director
Transaction date
Planned sale
Price
9.59
Quantity 40,000 -22.2%
Value US$383,600
MURRAY RICHARD /CA/ CEO and President Executive Director
Transaction date
Planned sale
Price
8.54
Quantity 30,000 -17.6%
Value US$256,200
1.9
Cole Hugh M Chief Business Officer Officer
Transaction date
Sale
Price
7.00
Quantity 3,340 -5.7%
Value US$23,380
MURRAY RICHARD /CA/ CEO and President Executive Director
Transaction date
Sale
Price
7.00
Quantity 11,816 -7.8%
Value US$82,712
Drapkin Kimberlee C CFO and Treasurer Officer
Transaction date
Sale
Price
7.00
Quantity 3,130 -5.3%
Value US$21,910
Trehu Elizabeth Chief Medical Officer Officer
Transaction date
Sale
Price
7.00
Quantity 2,846 -3.8%
Value US$19,922
Drapkin Kimberlee C CFO and Treasurer Officer
Transaction date
Sale
Price
6.76
Quantity 2,697 -4.4%
Value US$18,232
MURRAY RICHARD /CA/ CEO and President Executive Director
Transaction date
Sale
Price
6.76
Quantity 10,183 -6.3%
Value US$68,837
1.9
Cole Hugh M Chief Business Officer Officer
Transaction date
Sale
Price
6.76
Quantity 2,879 -4.7%
Value US$19,462
Trehu Elizabeth Chief Medical Officer Officer
Transaction date
Sale
Price
6.76
Quantity 2,452 -3.2%
Value US$16,576
Pfeffer Cary Non-Executive Director
Transaction date
Sale
Price
0.00
Quantity 0
Value US$0
Pfeffer Cary Non-Executive Director
Transaction date
Sale
Price
0.00
Quantity 0
Value US$0
Duncan Barbara Gayle Non-Executive Director
Transaction date
Planned sale
Price
10.50
Quantity 5,000 -100.0%
Value US$52,500
Duncan Barbara Gayle Non-Executive Director
Transaction date
Planned sale
Price
9.50
Quantity 5,000 -50.0%
Value US$47,500
Drapkin Kimberlee C CFO and Treasurer Officer
Transaction date
Planned sale
Price
8.06
Quantity 7,200 -10.4%
Value US$58,032
1.9
Cole Hugh M Chief Business Officer Officer
Transaction date
Sale
Price
4.71
Quantity 744 -1.2%
Value US$3,504
Drapkin Kimberlee C CFO and Treasurer Officer
Transaction date
Sale
Price
4.71
Quantity 744 -1.1%
Value US$3,504
1.9
Cole Hugh M Chief Business Officer Officer
Transaction date
Sale
Price
4.86
Quantity 454 -0.7%
Value US$2,206
Drapkin Kimberlee C CFO and Treasurer Officer
Transaction date
Sale
Price
4.86
Quantity 454 -0.6%
Value US$2,206
Trehu Elizabeth Chief Medical Officer Officer
Transaction date
Sale
Price
4.86
Quantity 454 -0.6%
Value US$2,206
Trehu Elizabeth Chief Medical Officer Officer
Transaction date
Sale
Price
4.71
Quantity 744 -1.0%
Value US$3,504
Drapkin Kimberlee C CFO and Treasurer Officer
Transaction date
Sale
Price
4.64
Quantity 984 -1.4%
Value US$4,566
Trehu Elizabeth Chief Medical Officer Officer
Transaction date
Sale
Price
4.64
Quantity 984 -1.2%
Value US$4,566
1.9
Cole Hugh M Chief Business Officer Officer
Transaction date
Sale
Price
4.64
Quantity 984 -1.5%
Value US$4,566
Trehu Elizabeth Chief Medical Officer
Transaction date
Sale
Price
7.78
Quantity 2,624 -4.4%
Value US$20,415
MURRAY RICHARD /CA/ CEO and President Executive Director
Transaction date
Sale
Price
7.78
Quantity 7,150 -7.6%
Value US$55,627
Drapkin Kimberlee C CFO and Treasurer
Transaction date
Sale
Price
7.78
Quantity 2,624 -5.6%
Value US$20,415
1.9
Cole Hugh M Chief Business Officer
Transaction date
Sale
Price
7.78
Quantity 2,624 -7.2%
Value US$20,415
MURRAY RICHARD /CA/ CEO and President Executive Director
Transaction date
Planned sale
Price
8.37
Quantity 40,000 -29.7%
Value US$334,800
Drapkin Kimberlee C CFO and Treasurer Officer
Transaction date
Sale
Price
3.92
Quantity 1,018 -2.1%
Value US$3,991
Cole Hugh M Chief Business Officer Officer
Transaction date
Sale
Price
3.92
Quantity 1,018 -2.7%
Value US$3,991
Trehu Elizabeth Chief Medical Officer Officer
Transaction date
Sale
Price
3.92
Quantity 1,018 -1.7%
Value US$3,991
Drapkin Kimberlee C CFO and Treasurer Officer
Transaction date
Sale
Price
4.00
Quantity 648 -1.3%
Value US$2,592
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2023-04-06 2023-04-04 PlS Planned sale Non-Executive Director
57,238 -33.9%
146.85
US$4,381,397
57,238 -33.9% 146.85 US$4,381,397
2023-03-14 2023-03-14 B Purchase Large shareholder
29,335 +32.4%
17.10
US$1,850,522
29,335 +32.4% 17.10 US$1,850,522
2023-03-14 2023-03-13 B Purchase Large shareholder
16,806 -9.0%
76.76
US$4,181,609
16,806 -9.0% 76.76 US$4,181,609
2023-01-11 2023-01-10 S Sale

Chief Operating Officer

Officer
9,182 -7.7%
1.12
US$10,284
9,182 -7.7% 1.12 US$10,284
2023-01-11 2023-01-10 S Sale

Chief Medical Officer

Officer
5,126 -4.7%
1.12
US$5,741
5,126 -4.7% 1.12 US$5,741
2023-01-11 2023-01-10 S Sale

CEO and President

Executive Director
24,879 -9.8%
1.12
US$27,864
24,879 -9.8% 1.12 US$27,864
2023-01-11 2023-01-10 S Sale

CFO and Treasurer

Officer
7,781 -10.5%
1.12
US$8,715
7,781 -10.5% 1.12 US$8,715
2023-01-11 2023-01-09 S Sale

Chief Operating Officer

Officer
7,452 -5.9%
1.10
US$8,197
7,452 -5.9% 1.10 US$8,197
2023-01-11 2023-01-09 S Sale

Chief Medical Officer

Officer
4,159 -3.7%
1.10
US$4,575
4,159 -3.7% 1.10 US$4,575
2023-01-11 2023-01-09 S Sale

CEO and President

Executive Director
20,191 -7.4%
1.10
US$22,210
20,191 -7.4% 1.10 US$22,210
2023-01-11 2023-01-09 S Sale

CFO and Treasurer

Officer
6,315 -7.9%
1.10
US$6,946
6,315 -7.9% 1.10 US$6,946
2023-01-09 2023-01-09 PrS Proposed sale

Officer

Officer
10,000
1.14
US$11,400
10,000 1.14 US$11,400
2023-01-09 2023-01-09 PrS Proposed sale

Officer

Officer
15,000
1.14
US$17,100
15,000 1.14 US$17,100
2023-01-09 2023-01-09 PrS Proposed sale

Officer; Director

Executive Director
45,000
1.14
US$51,300
45,000 1.14 US$51,300
2022-01-11 2022-01-10 S Sale

CFO and Treasurer

Officer
8,222 -13.5%
6.65
US$54,676
8,222 -13.5% 6.65 US$54,676
2022-01-11 2022-01-10 S Sale

Chief Medical Officer

Officer
5,378 -5.9%
6.65
US$35,764
5,378 -5.9% 6.65 US$35,764
2022-01-11 2022-01-10 S Sale

CEO and President

Executive Director
23,924 -11.4%
6.65
US$159,095
23,924 -11.4% 6.65 US$159,095
2022-01-11 2022-01-10 S Sale

Chief Business Officer

Officer
6,205 -8.8%
6.65
US$41,263
6,205 -8.8% 6.65 US$41,263
2022-01-11 2022-01-07 S Sale

CFO and Treasurer

Officer
4,595 -7.0%
7.30
US$33,544
4,595 -7.0% 7.30 US$33,544
2022-01-11 2022-01-07 S Sale

Chief Medical Officer

Officer
3,005 -3.2%
7.30
US$21,936
3,005 -3.2% 7.30 US$21,936
2022-01-11 2022-01-07 S Sale

CEO and President

Executive Director
13,370 -6.0%
7.30
US$97,601
13,370 -6.0% 7.30 US$97,601
2022-01-11 2022-01-07 S Sale

Chief Business Officer

Officer
3,468 -4.7%
7.30
US$25,316
3,468 -4.7% 7.30 US$25,316
2021-11-16 2021-11-12 S Sale Large shareholder
1,900,000 -62.3%
8.38
US$15,922,000
1,900,000 -62.3% 8.38 US$15,922,000
2021-11-16 2021-11-12 S Sale Non-Executive Director
0
0.00
US$0
0 0.00 US$0
2021-05-27 2021-05-25 S Sale Large shareholder
552,520 -8.5%
8.00
US$4,420,160
552,520 -8.5% 8.00 US$4,420,160
2021-04-16 2021-04-15 PlS Planned sale Non-Executive Director
200 -2.0%
10.00
US$2,000
200 -2.0% 10.00 US$2,000
2021-03-17 2021-03-15 PlS Planned sale Non-Executive Director
200 -2.0%
12.80
US$2,560
200 -2.0% 12.80 US$2,560
2021-03-03 2021-03-01 S Sale Non-Executive Director
0
0.00
US$0
0 0.00 US$0
2021-03-03 2021-03-01 S Sale Large shareholder
1,450,000 -15.8%
11.75
US$17,037,500
1,450,000 -15.8% 11.75 US$17,037,500
2021-02-18 2021-02-16 PlS Planned sale Non-Executive Director
200 -1.9%
11.78
US$2,356
200 -1.9% 11.78 US$2,356
2021-01-25 2021-01-22 PlS Planned sale

Chief Business Officer

Officer
18,000 -27.6%
11.95
US$215,100
18,000 -27.6% 11.95 US$215,100
2021-01-25 2021-01-21 PlS Planned sale

CEO and President

Executive Director
33,518 -19.3%
12.06
US$404,227
33,518 -19.3% 12.06 US$404,227
2021-01-22 2021-01-21 PlS Planned sale Non-Executive Director
200 -1.9%
11.11
US$2,222
200 -1.9% 11.11 US$2,222
2021-01-22 2021-01-21 PlS Planned sale

CFO and Treasurer

Officer
3,799 -8.1%
12.00
US$45,588
3,799 -8.1% 12.00 US$45,588
2021-01-22 2021-01-20 PlS Planned sale

CFO and Treasurer

Officer
10,000 -18.8%
10.03
US$100,300
10,000 -18.8% 10.03 US$100,300
2021-01-22 2021-01-20 PlS Planned sale

CFO and Treasurer

Officer
16,201 -23.4%
12.03
US$194,898
16,201 -23.4% 12.03 US$194,898
2021-01-22 2021-01-20 PlS Planned sale

Chief Medical Officer

Officer
6,500 -8.4%
12.01
US$78,065
6,500 -8.4% 12.01 US$78,065
2021-01-22 2021-01-20 PlS Planned sale Non-Executive Director
1,500 -12.5%
12.00
US$18,000
1,500 -12.5% 12.00 US$18,000
2021-01-20 2021-01-20 PlS Planned sale

CEO and President

Executive Director
16,482 -10.5%
12.04
US$198,443
16,482 -10.5% 12.04 US$198,443
2021-01-20 2021-01-19 PlS Planned sale

CEO and President

Executive Director
40,000 -22.2%
9.59
US$383,600
40,000 -22.2% 9.59 US$383,600
2021-01-20 2021-01-15 PlS Planned sale

CEO and President

Executive Director
30,000 -17.6%
8.54
US$256,200
30,000 -17.6% 8.54 US$256,200
2021-01-11 2021-01-08 S Sale

Chief Business Officer

Officer
3,340 -5.7%
7.00
US$23,380
3,340 -5.7% 7.00 US$23,380
2021-01-11 2021-01-08 S Sale

CEO and President

Executive Director
11,816 -7.8%
7.00
US$82,712
11,816 -7.8% 7.00 US$82,712
2021-01-11 2021-01-08 S Sale

CFO and Treasurer

Officer
3,130 -5.3%
7.00
US$21,910
3,130 -5.3% 7.00 US$21,910
2021-01-11 2021-01-08 S Sale

Chief Medical Officer

Officer
2,846 -3.8%
7.00
US$19,922
2,846 -3.8% 7.00 US$19,922
2021-01-11 2021-01-07 S Sale

CFO and Treasurer

Officer
2,697 -4.4%
6.76
US$18,232
2,697 -4.4% 6.76 US$18,232
2021-01-11 2021-01-07 S Sale

CEO and President

Executive Director
10,183 -6.3%
6.76
US$68,837
10,183 -6.3% 6.76 US$68,837
2021-01-11 2021-01-07 S Sale

Chief Business Officer

Officer
2,879 -4.7%
6.76
US$19,462
2,879 -4.7% 6.76 US$19,462
2021-01-11 2021-01-07 S Sale

Chief Medical Officer

Officer
2,452 -3.2%
6.76
US$16,576
2,452 -3.2% 6.76 US$16,576
2020-11-23 2020-11-19 S Sale Non-Executive Director
0
0.00
US$0
0 0.00 US$0
2020-11-23 2020-11-19 S Sale Large shareholder
15,000 -0.2%
7.01
US$105,075
15,000 -0.2% 7.01 US$105,075
2020-11-19 2020-11-17 S Sale Large shareholder
15,000 -0.2%
7.25
US$108,772
15,000 -0.2% 7.25 US$108,772
2020-11-19 2020-11-17 S Sale Non-Executive Director
0
0.00
US$0
0 0.00 US$0
2020-09-16 2020-09-15 PlS Planned sale Non-Executive Director
5,000 -100.0%
10.50
US$52,500
5,000 -100.0% 10.50 US$52,500
2020-09-16 2020-09-15 PlS Planned sale Non-Executive Director
5,000 -50.0%
9.50
US$47,500
5,000 -50.0% 9.50 US$47,500
2020-09-02 2020-09-01 PlS Planned sale

CFO and Treasurer

Officer
7,200 -10.4%
8.06
US$58,032
7,200 -10.4% 8.06 US$58,032
2020-08-18 2020-08-18 S Sale

Chief Business Officer

Officer
744 -1.2%
4.71
US$3,504
744 -1.2% 4.71 US$3,504
2020-08-18 2020-08-18 S Sale

CFO and Treasurer

Officer
744 -1.1%
4.71
US$3,504
744 -1.1% 4.71 US$3,504
2020-08-18 2020-08-17 S Sale

Chief Business Officer

Officer
454 -0.7%
4.86
US$2,206
454 -0.7% 4.86 US$2,206
2020-08-18 2020-08-17 S Sale

CFO and Treasurer

Officer
454 -0.6%
4.86
US$2,206
454 -0.6% 4.86 US$2,206
2020-08-18 2020-08-17 S Sale

Chief Medical Officer

Officer
454 -0.6%
4.86
US$2,206
454 -0.6% 4.86 US$2,206
2020-08-18 2020-08-14 S Sale

Chief Medical Officer

Officer
744 -1.0%
4.71
US$3,504
744 -1.0% 4.71 US$3,504
2020-08-18 2020-08-14 S Sale

CFO and Treasurer

Officer
984 -1.4%
4.64
US$4,566
984 -1.4% 4.64 US$4,566
2020-08-18 2020-08-14 S Sale

Chief Medical Officer

Officer
984 -1.2%
4.64
US$4,566
984 -1.2% 4.64 US$4,566
2020-08-18 2020-08-14 S Sale

Chief Business Officer

Officer
984 -1.5%
4.64
US$4,566
984 -1.5% 4.64 US$4,566
2020-01-10 2020-01-07 S Sale

Chief Medical Officer

2,624 -4.4%
7.78
US$20,415
2,624 -4.4% 7.78 US$20,415
2020-01-10 2020-01-07 S Sale

CEO and President

Executive Director
7,150 -7.6%
7.78
US$55,627
7,150 -7.6% 7.78 US$55,627
2020-01-10 2020-01-07 S Sale

CFO and Treasurer

2,624 -5.6%
7.78
US$20,415
2,624 -5.6% 7.78 US$20,415
2020-01-10 2020-01-07 S Sale

Chief Business Officer

2,624 -7.2%
7.78
US$20,415
2,624 -7.2% 7.78 US$20,415
2020-01-08 2020-01-06 PlS Planned sale
1,500 -11.1%
8.11
US$12,165
1,500 -11.1% 8.11 US$12,165
2019-12-26 2019-12-23 PlS Planned sale MURRAY RICHARD /CA/

CEO and President

Executive Director
40,000 -29.7%
8.37
US$334,800
40,000 -29.7% 8.37 US$334,800
2019-08-16 2019-08-16 S Sale Drapkin Kimberlee C

CFO and Treasurer

Officer
1,018 -2.1%
3.92
US$3,991
1,018 -2.1% 3.92 US$3,991
2019-08-16 2019-08-16 S Sale Cole Hugh M

Chief Business Officer

Officer
1,018 -2.7%
3.92
US$3,991
1,018 -2.7% 3.92 US$3,991
2019-08-16 2019-08-16 S Sale Trehu Elizabeth

Chief Medical Officer

Officer
1,018 -1.7%
3.92
US$3,991
1,018 -1.7% 3.92 US$3,991
2019-08-16 2019-08-15 S Sale

CFO and Treasurer

Officer
648 -1.3%
4.00
US$2,592
648 -1.3% 4.00 US$2,592

See older Jounce Therapeutics Inc insider trades

Plus unlocks the full transaction history.

See localized pricing at checkout
Unlock Jounce Therapeutics Inc history with Plus

Billed monthly · Cancel anytime